UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 18, 2023 5:30 P.M.
Form:
F-1
CIK:
0001643918
Company Name:
Biodexa Pharmaceuticals Plc
File Number:
333-274895